C12N 2730/10161
Methods of inactivation or attenuation
C12N2730/10161 (Methods of inactivation or attenuation) appears on 18 US grants and 25 published applications in this corpus.
Search patents in C12N- Granted patents
- 18
- Published applications
- 25
- Assignees
- 14
- Inventors
- 36
- Latest grant
- 19 Nov 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 3 |
| 2004 | 0 | 2 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 2 |
| 2008 | 3 | 5 |
| 2009 | 1 | 2 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 2 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 2 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 2 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Methods for inactivating, on medical instruments and devices, viruses containing RNA and DNA, and apparatuses for implementating same19 Nov 2019US 10,478,514 B2
- Nucleic acid amplification controls8 Sep 2015US 9,127,048 B2ZeptoMetrix Corporation
- Nucleic acid amplification controls1 Sep 2015US 9,120,849 B2ZeptoMetrix Corporation
- SARS vaccine compositions and methods of making and using them13 Aug 2013US 8,506,968 B2Eli Lilly and Company
- Viral capsid assembly intermediates and methods of production29 Dec 2009US 7,638,269 B2The Regents of the University of California
- Hepatitis b virus (hbv) knockouts24 Oct 2024US 2024/0350665 A1EmendoBio Inc.
- Compositions and methods for treating hepatitis b virus infection5 Sep 2024US 2024/0294914 A1Beam Therapeutics Inc.
- Methods for inactivating, on medical instruments and devices, viruses containing rna and dna, and apparatuses for implementating same2 Apr 2020US 2020/0101182 A1
- Nucleic acid amplification controls20 Apr 2017US 2017/0107585 A1ZeptoMetrix Corporation
- Methods for inactivating, on medical instruments and devices, viruses containing rna and dna, and apparatuses for implementating same2 Mar 2017US 2017/0056538 A1
Most cited
By later US patents
- Recombinant hepatitis virus vectors115US 5,981,274 A1999
- Method for inactivating pathogens in red cell compositions using quinacrine mustard63US 5,691,132 ACerus Corporation · 1997
- Treating red blood cell solutions with anti-viral agents57US 5,559,250 ASteritech, Inc. · 1996
- Treating blood or blood product with a compound having a mustard and a nucleic acid binding moiety47US 6,171,777 B2Cerus Corporation · 2001
- Treating blood or blood products with compounds which have a mustard, azirdinium or aziridine group and a nucleic acid binding group36US 6,410,219 B1Cerus Corporation · 2002